Literature DB >> 28198010

Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism.

Morena Zusso1, Giulia Mercanti1, Federica Belluti2, Rita Maria Concetta Di Martino2, Andrea Pagetta1, Carla Marinelli1, Paola Brun3, Eugenio Ragazzi1, Rita Lo4, Stefano Stifani4, Pietro Giusti1, Stefano Moro5.   

Abstract

BACKGROUND AND
PURPOSE: Toll-like receptor 4 (TLR4) plays a key role in the induction of inflammatory responses both in peripheral organs and the CNS. Curcumin exerts anti-inflammatory functions by interfering with LPS-induced dimerization of TLR4-myeloid differentiation protein-2 (MD-2) complex and suppressing pro-inflammatory mediator release. However, the inhibitory mechanism of curcumin remains to be defined. EXPERIMENTAL APPROACH: Binding of bis-demethoxycurcumin (GG6) and its cyclized pyrazole analogue (GG9), lacking the 1,3-dicarbonyl function, to TLR4-MD-2 was determined using molecular docking simulations. The effects of these compounds on cytokine release and NF-κB activation were examined by ELISA and fluorescence staining in LPS-stimulated primary microglia. Interference with TLR4 dimerization was assessed by immunoprecipitation in Ba/F3 cells. KEY
RESULTS: Both curcumin analogues bound to the hydrophobic region of the MD-2 pocket. However, only curcumin and GG6, both possessing the 1,3-diketone moiety, inhibited LPS-induced TLR4 dimerization, activation of NF-κB and secretion of pro-inflammatory cytokines in primary microglia. Consistent with the ability of 1,3-diketones to coordinate divalent metal ions, LPS stimulation in a low magnesium environment decreased pro-inflammatory cytokine release and NF-κB p65 nuclear translocation in microglia and decreased TLR4-MD-2 dimerization in Ba/F3 cells. Curcumin and GG6 also significantly reduced cytokine output in contrast to the pyrazole analogue GG9. CONCLUSIONS AND IMPLICATIONS: These results indicate that phenolic 1,3-diketones, with a structural motif able to coordinate magnesium ions, can modulate LPS-mediated TLR4-MD-2 signalling. Taken together, these studies identify a previously uncharacterized mechanism involving magnesium, underlying the inflammatory responses to LPS.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28198010      PMCID: PMC5406298          DOI: 10.1111/bph.13746

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  52 in total

1.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Insights into the binding mode of curcumin to MD-2: studies from molecular docking, molecular dynamics simulations and experimental assessments.

Authors:  Zhe Wang; Gaozhi Chen; Linfeng Chen; Xing Liu; Weitao Fu; Yali Zhang; Chenglong Li; Guang Liang; Yuepiao Cai
Journal:  Mol Biosyst       Date:  2015-07

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

Review 4.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

5.  L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate.

Authors:  C Y Lin; P S Tsai; Y C Hung; C J Huang
Journal:  Br J Anaesth       Date:  2010-01       Impact factor: 9.166

6.  MD-2 as the target of curcumin in the inhibition of response to LPS.

Authors:  Helena Gradisar; Mateja Mancek Keber; Primoz Pristovsek; Roman Jerala
Journal:  J Leukoc Biol       Date:  2007-07-03       Impact factor: 4.962

7.  MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.

Authors:  R Shimazu; S Akashi; H Ogata; Y Nagai; K Fukudome; K Miyake; M Kimoto
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

8.  Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.

Authors:  Yali Zhang; Dandan Liang; Lili Dong; Xiangting Ge; Fengli Xu; Wenbo Chen; Yuanrong Dai; Huameng Li; Peng Zou; Shulin Yang; Guang Liang
Journal:  Respir Res       Date:  2015-03-24

9.  Does neuroinflammation fan the flame in neurodegenerative diseases?

Authors:  Tamy C Frank-Cannon; Laura T Alto; Fiona E McAlpine; Malú G Tansey
Journal:  Mol Neurodegener       Date:  2009-11-16       Impact factor: 14.195

Review 10.  Innate immunity and neuroinflammation.

Authors:  Abhishek Shastri; Domenico Marco Bonifati; Uday Kishore
Journal:  Mediators Inflamm       Date:  2013-06-15       Impact factor: 4.711

View more
  7 in total

1.  Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism.

Authors:  Morena Zusso; Giulia Mercanti; Federica Belluti; Rita Maria Concetta Di Martino; Andrea Pagetta; Carla Marinelli; Paola Brun; Eugenio Ragazzi; Rita Lo; Stefano Stifani; Pietro Giusti; Stefano Moro
Journal:  Br J Pharmacol       Date:  2017-03-31       Impact factor: 8.739

2.  Modulation of Amyloid β-Induced Microglia Activation and Neuronal Cell Death by Curcumin and Analogues.

Authors:  Ersilia De Lorenzi; Davide Franceschini; Cecilia Contardi; Rita Maria Concetta Di Martino; Francesca Seghetti; Massimo Serra; Federica Bisceglia; Andrea Pagetta; Morena Zusso; Federica Belluti
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

3.  Bisdemethoxycurcumin and Its Cyclized Pyrazole Analogue Differentially Disrupt Lipopolysaccharide Signalling in Human Monocyte-Derived Macrophages.

Authors:  Serena Tedesco; Morena Zusso; Laura Facci; Annalisa Trenti; Carlotta Boscaro; Federica Belluti; Gian Paolo Fadini; Stephen D Skaper; Pietro Giusti; Chiara Bolego; Andrea Cignarella
Journal:  Mediators Inflamm       Date:  2018-02-08       Impact factor: 4.711

4.  Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease.

Authors:  Rita Maria Concetta Di Martino; Letizia Pruccoli; Alessandra Bisi; Silvia Gobbi; Angela Rampa; Ana Martinez; Concepción Pérez; Loreto Martinez-Gonzalez; Maria Paglione; Elia Di Schiavi; Francesca Seghetti; Andrea Tarozzi; Federica Belluti
Journal:  ACS Chem Neurosci       Date:  2020-08-03       Impact factor: 4.418

5.  The Effect of C-Phycocyanin on Microglia Activation Is Mediated by Toll-like Receptor 4.

Authors:  Anna Piovan; Raffaella Filippini; Carla Argentini; Stefano Moro; Pietro Giusti; Morena Zusso
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

6.  Curcumin Prevents Acute Neuroinflammation and Long-Term Memory Impairment Induced by Systemic Lipopolysaccharide in Mice.

Authors:  Vincenzo Sorrenti; Gabriella Contarini; Stefania Sut; Stefano Dall'Acqua; Francesca Confortin; Andrea Pagetta; Pietro Giusti; Morena Zusso
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

Review 7.  The Emerging Role of Curcumin in the Modulation of TLR-4 Signaling Pathway: Focus on Neuroprotective and Anti-Rheumatic Properties.

Authors:  Maria Antonietta Panaro; Addolorata Corrado; Tarek Benameur; Cantatore Francesco Paolo; Daniela Cici; Chiara Porro
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.